| 发明名称 |
Krystallinsk form av et ribofuranosyl-derivat; en human adenosin A2A reseptorantagonist |
| 摘要 |
The present invention relates to a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and to a process for the preparation of, compositions containing and the uses of such a crystalline form. |
| 申请公布号 |
NO20042837(A) |
申请公布日期 |
2004.08.24 |
| 申请号 |
NO20040002837 |
申请日期 |
2004.07.05 |
| 申请人 |
PFIZER INC |
发明人 |
SILK TERENCE VERNON;SMITH JULIAN DUNCAN |
| 分类号 |
C07H19/167;A61K31/46;A61K31/4745;A61K31/70;A61K31/7076;A61K47/48;A61P1/00;A61P1/04;A61P3/10;A61P7/00;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P15/10;A61P15/12;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P19/02;A61P25/00;A61P25/08;A61P27/16;A61P29/00;A61P37/08;A61P43/00;C07H19/16 |
主分类号 |
C07H19/167 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
